Your session is about to expire
← Back to Search
Exercise for Pediatric Cancer
N/A
Recruiting
Led By Jennifer Pope, MD
Research Sponsored by Jamie Mochel
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages 2-25 at time of consent
Ability of subject (and/or parent/guardian) to read and understand the English or Spanish language
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 month period
Awards & highlights
Study Summary
This trial will test if there are benefits to exercise for people newly diagnosed with cancer.
Who is the study for?
This trial is for children and young adults aged 2-25 who have been newly diagnosed with blood or solid tumor cancers, excluding osteosarcoma and primary CNS tumors. Participants must be starting or undergoing cancer treatment expected to last at least 3 months, able to understand English or Spanish, and capable of following the study's procedures.Check my eligibility
What is being tested?
The trial is testing two exercise programs: a standard care routine versus a 'Just Move' regimen. It aims to determine if structured physical activity can provide physical and emotional benefits during cancer treatment for pediatric patients.See study design
What are the potential side effects?
While specific side effects are not detailed for exercise interventions, participants may experience general fatigue or discomfort associated with increased physical activity. Any significant health risks will be assessed by investigators based on individual conditions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 2 and 25 years old.
Select...
I (or my parent/guardian) can read and understand English or Spanish.
Select...
I have been recently diagnosed with cancer and plan to start chemotherapy.
Select...
I am expected to undergo cancer treatment for at least 3 months.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Potential benefit of increasing/maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment
Secondary outcome measures
Adverse Event Rate
Adverse Events Related to Exercise Program
Quality of Life measured by the PedsQL Cancer Module
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: SOC EXERExperimental Treatment1 Intervention
Standard of Care Exercise
Group II: EXERExperimental Treatment1 Intervention
"Just Move" exercises
Find a Location
Who is running the clinical trial?
Jamie MochelLead Sponsor
Atrium Health Levine Cancer InstituteOTHER
18 Previous Clinical Trials
1,474 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,250 Previous Clinical Trials
1,007,118 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had or will have surgery soon that limits my movement significantly.I have been diagnosed with osteosarcoma.I am between 2 and 25 years old.I (or my parent/guardian) can read and understand English or Spanish.I have been recently diagnosed with cancer and plan to start chemotherapy.I am expected to undergo cancer treatment for at least 3 months.I understand and can follow the study's procedures.My cancer originated in the brain or spinal cord.
Research Study Groups:
This trial has the following groups:- Group 1: EXER
- Group 2: SOC EXER
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger